Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The intervention categories synthesized in this review, namely omega-3 fatty acids, ketogenic dietary interventions, B-vitamin supplementation, vitamin D, and microbiota-targeted strategies, emerged from the available evidence that satisfied the inclusion criteria and reported neuroinflammatory outcomes relevant to the objectives of this review.
Source: Introduction. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Nutritional modulation of neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a systematic review of clinical and preclinical evidence
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Nutritional modulation of neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a systematic review of clinical and preclinical evidence
Systematic review · BMC Geriatrics · 2026
Original publication title
Nutritional modulation of neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a systematic review of clinical and preclinical evidence
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Neuroinflammationis a key contributor to the pathogenesis of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Nutritional interventions have been proposed as potential modulators of neuroinflammatory pathways; however, the consistency and strength of the available evidence remain uncertain. This systematic review evaluated the clinical and preclinical evidence regarding the effects of nutritional interventions on neuroinflammatory mechanisms relevant to AD and MCI.
Source: BackgroundAbstract: What methods does the paper describe?
PubMed/MEDLINE, Embase, Scopus, and Web of Science were systematically searched for studies investigating nutritional interventions and neuroinflammatory outcomes. Eligible studies included randomized controlled trials and preclinical experimental investigations evaluating omega-3 fatty acids, ketogenic dietary interventions, B-vitamin supplementation, vitamin D, and microbiota-targeted strategies. Primary outcomes included inflammatory cytokines, neuroinflammatory signaling pathways, oxidative stress biomarkers, and glial activation. Methodological quality and risk of bias were assessed using study design-specific appraisal tools.
Source: MethodsAbstract: Results
Twenty-two studies met the eligibility criteria, including ten clinical studies and twelve preclinical investigations. Overall, nutritional interventions were associated with modulation of neuroinflammatory biomarkers, including TNF-α, IL-1β, and IL-6, together with alterations in NF-κB and NLRP3 signaling, microglial activation, and oxidative stress pathways. The most consistent evidence supported omega-3 fatty acids and ketogenic dietary interventions, although evidence for ketogenic strategies was derived predominantly from preclinical studies. Evidence for B-vitamin supplementation, vitamin D, and microbiota-targeted interventions was limited because relatively few eligible studies were available.
Considerable heterogeneity was observed across intervention protocols, outcome measures, and study populations.
Source: ResultsAbstract: Conclusions
Nutritional interventions may modulate biological pathways involved in neuroinflammation; however, the strength and certainty of the evidence vary across intervention categories. Larger, well-designed randomized controlled trials incorporating standardized neuroinflammatory biomarkers are required to clarify the therapeutic potential of nutritional strategies for AD and MCI.
Source: ConclusionsAuthors’ abstract
Background
Neuroinflammationis a key contributor to the pathogenesis of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Nutritional interventions have been proposed as potential modulators of neuroinflammatory pathways; however, the consistency and strength of the available evidence remain uncertain. This systematic review evaluated the clinical and preclinical evidence regarding the effects of nutritional interventions on neuroinflammatory mechanisms relevant to AD and MCI.
Methods
PubMed/MEDLINE, Embase, Scopus, and Web of Science were systematically searched for studies investigating nutritional interventions and neuroinflammatory outcomes. Eligible studies included randomized controlled trials and preclinical experimental investigations evaluating omega-3 fatty acids, ketogenic dietary interventions, B-vitamin supplementation, vitamin D, and microbiota-targeted strategies. Primary outcomes included inflammatory cytokines, neuroinflammatory signaling pathways, oxidative stress biomarkers, and glial activation. Methodological quality and risk of bias were assessed using study design-specific appraisal tools.
Results
Twenty-two studies met the eligibility criteria, including ten clinical studies and twelve preclinical investigations. Overall, nutritional interventions were associated with modulation of neuroinflammatory biomarkers, including TNF-α, IL-1β, and IL-6, together with alterations in NF-κB and NLRP3 signaling, microglial activation, and oxidative stress pathways. The most consistent evidence supported omega-3 fatty acids and ketogenic dietary interventions, although evidence for ketogenic strategies was derived predominantly from preclinical studies. Evidence for B-vitamin supplementation, vitamin D, and microbiota-targeted interventions was limited because relatively few eligible studies were available.
Considerable heterogeneity was observed across intervention protocols, outcome measures, and study populations.
Conclusions
Nutritional interventions may modulate biological pathways involved in neuroinflammation; however, the strength and certainty of the evidence vary across intervention categories. Larger, well-designed randomized controlled trials incorporating standardized neuroinflammatory biomarkers are required to clarify the therapeutic potential of nutritional strategies for AD and MCI.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12877-026-08126-x.
Publication and source details
Original title: Nutritional modulation of neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a systematic review of clinical and preclinical evidence
Mahmoud AL Sayed; Ahmed Said; Mohamed Meselhy
BMC Geriatrics · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Benha UniversityOpen access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:50:21.659095+00:00
DOI: 10.1186/s12877-026-08126-x · PMC13520152